|
MechanismTHBS1 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismSmad proteins inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismTGF-β inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chengdu Huitai Biomedicine Co
0 Patents (Medical) associated with Chengdu Huitai Biomedicine Co
100 Deals associated with Chengdu Huitai Biomedicine Co
100 Translational Medicine associated with Chengdu Huitai Biomedicine Co